Analytical Lens: Exploring Fate Therapeutics Inc (FATE)’s Financial Story Through Ratios

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

In other words, the price has increased by $0.00 from its previous closing price. On the day, 1.21 million shares were traded. FATE stock price reached its highest trading level at $1.155 during the session, while it also had its lowest trading level at $1.11.

Ratios:

Our analysis of FATE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.81 and its Current Ratio is at 8.81. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.27.

On June 17, 2024, Piper Sandler Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $4 to $6.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 06 ’25 when Wolchko J Scott bought 113,178 shares for $0.93 per share.

Bressi Jerome Charles sold 5,980 shares of FATE for $9,269 on Jan 10 ’25. The insider now owns 270,203 shares after completing the transaction at $1.55 per share. On Jan 10 ’25, another insider, TAHL CINDY, who serves as the insider of the company, sold 5,654 shares for $1.55 each. As a result, the insider received 8,764 and left with 336,707 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FATE now has a Market Capitalization of 128388960 and an Enterprise Value of -28704016. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.62 while its Price-to-Book (P/B) ratio in mrq is 0.45. Its current Enterprise Value per Revenue stands at -2.153 whereas that against EBITDA is 0.171.

Stock Price History:

The Beta on a monthly basis for FATE is 2.24, which has changed by -0.64102566 over the last 52 weeks, in comparison to a change of 0.12677538 over the same period for the S&P500. Over the past 52 weeks, FATE has reached a high of $5.92, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is -8.08%, while the 200-Day Moving Average is calculated to be -36.19%.

Shares Statistics:

FATE traded an average of 2.11M shares per day over the past three months and 1854850 shares per day over the past ten days. A total of 114.60M shares are outstanding, with a floating share count of 107.09M. Insiders hold about 6.58% of the company’s shares, while institutions hold 84.22% stake in the company. Shares short for FATE as of 1749772800 were 9512319 with a Short Ratio of 4.51, compared to 1747267200 on 12870954. Therefore, it implies a Short% of Shares Outstanding of 9512319 and a Short% of Float of 9.4799995.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.